|
Qian, G S; Ross, R K; Yu, M C et al. (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 3:3-10
|
|
Groopman, J D; Roebuck, B D; Kensler, T W (1994) Carcinogen-DNA and protein adducts as intermediate biomarkers for human chemoprotection trials. Adv Exp Med Biol 354:149-60
|
|
Wild, C P; Jansen, L A; Cova, L et al. (1993) Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus. Environ Health Perspect 99:115-22
|
|
Hollstein, M C; Wild, C P; Bleicher, F et al. (1993) p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand. Int J Cancer 53:51-5
|
|
Groopman, J D; Wild, C P; Hasler, J et al. (1993) Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans. Environ Health Perspect 99:107-13
|
|
Wild, C P; Fortuin, M; Donato, F et al. (1993) Aflatoxin, liver enzymes, and hepatitis B virus infection in Gambian children. Cancer Epidemiol Biomarkers Prev 2:555-61
|
|
Sheabar, F Z; Groopman, J D; Qian, G S et al. (1993) Quantitative analysis of aflatoxin-albumin adducts. Carcinogenesis 14:1203-8
|
|
Hudson, G J; Wild, C P; Zarba, A et al. (1992) Aflatoxins isolated by immunoaffinity chromatography from foods consumed in The Gambia, West Africa. Nat Toxins 1:100-5
|
|
Zarba, A; Wild, C P; Hall, A J et al. (1992) Aflatoxin M1 in human breast milk from The Gambia, west Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC. Carcinogenesis 13:891-4
|
|
Groopman, J D; Roebuck, B D; Kensler, T W (1992) Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models. Prog Clin Biol Res 374:139-55
|
Showing the most recent 10 out of 18 publications
